INTRODUCTION
Tartrate-resistant acid phosphatase is either undetectable or barely detectable in normal tissues except bone [1] , where it can be identified histochemically in osteoclasts [2, 3] . Histochemical demonstration of the enzyme is frequently used for the specific identification of osteoclasts in tissues. During bone resorption, osteoclasts secrete acid hydrolases, including tartrate-resistant acid phosphatase [4, 5] , in a hormone-responsive manner. Increased concentrations of tartrate-resistant acid phosphatase are detectable in serum in physiological and pathological circumstances associated with increased bone resorption [6] [7] [8] [9] . Tartrate-resistant acid phosphatase also appears in circulating white cells and enlarged spleens of patients with hairy-cell leukaemia [10] , in spleens and sera of patients with Gaucher's disease [11] , and in macrophages after incubation in vitro [12] . Although the tartrate-resistant acid phosphatases from patients with Gaucher's disease and leukaemic reticuloendotheliosis have been characterized [11, 1 3-16] , the extent to which these resemble the major physiological source of the enzyme (osteoclasts) has not been clearly defined. This is largely because, although osteoclasts contain large amounts of the enzyme, they are numerically a very small cell population, and it has been difficult to obtain sufficient cells for full characterization of the enzyme. The only practicable source of osteoclasts in numbers sufficiently large for enzyme characterization is the giant cell tumour of bone, a very rare neoplasm that can be obtained in gram quantities and which contains relatively large numbers of osteoclasts [17, 18] . We used tissue from giant cell tumours to extract and purify the enzyme, to enable comparison with the properties of tartrate-resistant acid phosphatases from other sources. Such information may assist in the identification of the role for this enzyme in bone resorption, and may enable development of more specific and sensitive means of identification of osteoclastic phenotype and assessment of osteoclastic function.
EXPERIMENTAL Materials
Sephadex G-150, sulphopropyl (SP)-Sephadex, CM-Sephadex and concanavalin A-Sepharose were obtained from Pharmacia Fine Chemicals. Hydroxylapatite and the silver stain kit were from Bio-Rad Laboratories. Cellulose powder was from Whatman. SDS was obtained from Koch-Light, and cirrasol ALN-WF (a non-ionic detergent) from I.C.I. (Specialist Chemicals) Ltd., Leatherhead, Surrey, U.K. All substrates and chemicals were of analytical grade and were obtained from either Abbreviation used: SP-Sephadex, sulphopropyl-Sephadex. § To whom correspondence should be addressed. BDH Ltd. or Sigma Chemical Co. Osteoclastomas were collected immediately after surgery and were stored at 70°C. Determination of acid phosphatase activity Enzyme activity was measured fluorimetrically. The mixture, containing enzyme, 1.0 mM-4-methylumbelliferyl phosphate, 50 mM-disodium tartrate and 0.1 Msodium acetate, pH 5.7, in a final volume of 0.2 ml, was incubated at 37°C for 1-5 min. The reaction was terminated by the addition of 0.8 ml of 0.2 M-sodium phosphate-glycinate buffer, pH 10.4 [5] . The fluorescence of the 4-methylumbelliferone liberated was measured using a Locarte model 8-9 fluorimeter. One unit of enzyme activity corresponds to the hydrolysis of 1 ,umol of substrate/min.
The release of phosphate generated from assays involving phosphorylated compounds was determined spectrophotometrically based on the method of Atkinson et al. [19] . The mixture, containing enzyme, 0.25-4.0 mMsubstrate, 0.1 M-sodium acetate, pH 5.7, in a final volume of 0.2 ml, was incubated at 37°C for 20 min. The reaction was terminated by the addition of 0.3 ml of 5 aqueous cirrasol ALN-WF/2 ammonium molybdate/0.4 Macetic acid (20:50:30, by vol.). After mixing, 0.3 ml of 2.5 SDS in 5 mM-EDTA, pH 8.0/5 ascorbic acid/0.4 M-acetic acid (50:20:30, by vol.) was added. The phosphomolybdic acid produced was measured at 700 nm against a water blank after 20-30 min at 25 'C. A standard curve was constructed using potassium dihydrogen orthophosphate. Absorbance was measured after 20 min as for the test samples.
In kinetic experiments, the concentration of substrate ranged from 0.25 to 4.0 mm. The reaction was linear with time and over the range of enzyme concentration used throughout these experiments.
Protein determination
Protein concentrations were determined fluorimetrically [20] . The aqueous protein (0.5 ml), mixed with 0.75 ml of 0.1 M-sodium borate buffer, pH 9.2, was vortexed with 0.25 ml of fluorescamine (0.2 mg ml-' in acetone), and the products measured fluorimetrically. Bovine serum albumin was used as a standard. Purification of tartrate-resistant acid phosphatase from osteoclastomas All procedures were carried out at 4°C unless stated otherwise. The standard buffer contained 10 mM-sodium acetate, pH 5.5, 0.020% sodium azide and 0.1 mmphenylmethanesulphonyl fluoride. Acid phosphatase was determined using the fluorimetric method.
Step 1: Homogenization. Frozen tissue (20 g) was thawed and homogenized in a Waring blender with 8 vol. (w/v) of 50 mM-Tris/HCl buffer, pH 8.0, containing 0.1 M-NaCl and 0.1 mM-phenylmethanesulphonyl fluoride. Two vol. of 5 (v/v) Triton X-100 in the same buffer were added to the homogenate which was then stirred overnight. The homogenate was centrifuged for 2 h at 12000 g, and the supernatant was dialysed exhaustively against the standard buffer containing 0.1 M-NaCl, followed by further centrifugation for 2 h at 12000 g.
Step 2: SP-Sephadex chromatography. The super-natant from step 1 was applied to a 2.6 cm x 35 cm SP-Sephadex column equilibrated in the same buffer.
After thorough washing of the column with 500 ml of the equilibration buffer, the tartrate-resistant acid phosphatase was eluted with 2 x 500 ml linear gradients of 0.1-0.5 Mand 0.5-1.0 M-NaCl. Fractions (9 ml) were collected and assayed for acid phosphatase activity. Active fractions were pooled and dialysed against the standard buffer.
Step 3: CM-Sephadex chromatography. The tartrateresistant enzyme from the previous step was applied to a 1.6 cm x 20 cm CM-Sephadex-C50 column equilibrated in the standard buffer containing 0.1 M-NaCl. A 400 ml linear gradient of 0.1-1.0 M-NaCl in the same buffer was applied to elute the enzyme. Acid phosphatase activity was determined and active fractions were pooled and dialysed against the standard buffer containing 0.1 M-NaCl.
Step 4: Hydroxylapatite chromatography. The enzyme from step 3 was applied to a 1.6 cm x 10 cm column containing hydroxylapatite/cellulose powder (2: 1, w/w) equilibrated in the standard buffer containing 0.1 M-NaCl. The column was eluted with 300 ml of a 0-0.5 M linear ammonium sulphate gradient in the same buffer. Acid phosphatase activity was determined and active fractions were pooled and dialysed exhaustively against water.
Step 5: Sephadex G-150 gel-filtration chromatography. Acid phosphatase from step 4 was lyophilized and applied in a 0.5 ml vol. of the standard buffer containing 0.1 M-NaCl to a 1.6 cm x 100 cm Sephadex G-150 column previously equilibrated in the same buffer. The active fractions were pooled.
Step 6: Concanavalin A-Sepharose chromatography. The pooled enzyme from the previous step was adjusted to pH 6.5 with solid sodium acetate and the NaCl concentration increased to 0.5 M. This was applied at 25°C to a 1 cm x 10 cm column of concanavalin A-Sepharose previously equilibrated in 10 mM-sodium acetate buffer, pH 6.5, containing 0.5 M-NaCl. The enzyme was eluted at 4°C using the same buffer supplemented with 0.4 M-cx-methyl mannoside and 30 0 (v/v) ethyleneglycol. Fractions containing acid phosphatase activity were pooled, dialysed against water and lyophilized.
The purified enzyme was stored at -20°C in a solution of the standard buffer containing 0.1 M-NaCl and 30 0 (v/v) glycerol.
Structural studies
The enzyme (10,ug) was dissolved in 150 ,ul of acetonitrile/water (1: 1, v/v), and ammonium bicarbonate added to 150 mm and guanidine hydrochloride to 6 M. Mercaptoethanol (1 ul) was added and the mixture incubated for 1 h at 37°C in a sealed tube under N2. 4-Vinylpyridine (1.5 ,ul) was added and the incubation was continued for 16 h at 37 'C. The reaction mixture was applied to a Brownlee Aquapore RP300, C-8 reversephase h.p.l.c. column (50 mm x 2.1 mm) and eluted with a gradient of 10-65 Qo acetonitrile in water containing 0.05 0 trifluoroacetic acid. Amino acid sequence analysis of the separated subunits was carried out by Edman degradation using an Applied Biosystems 470A protein sequencer, and h.p.l.c. analysis of phenylthiohydantoin (PTH)-derivatized amino acids. The average repetitive yield was 85.8 % for the A subunit and 96.70 for the B subunit. Electrophoresis SDS/polyacrylamide-gel electrophoresis was performed according to the method of Laemmli [21] . SDS/polyacrylamide gels were stained using a silver stain kit obtained from Bio-Rad.
Mr determination by gel filtration
Acid phosphatase was chromatographed on a Sephadex G-150 column as described in purification step 5. The void volume was measured using Dextran Blue and the total volume determined using Page Blue 83. Aldolase (158000), haemoglobin (70000), bovine serum albumin (67000), ovalbumin (43000) and cytochrome c (12000) were used as Mr markers. The elution volume of acid phosphatase was determined by enzymic activity measured fluorimetrically, whereas each standard was determined by absorbance at 280 nm. 
Metal determination
The metal composition of the enzyme was determined by atomic absorption spectroscopy by Butterworth Laboratories, Twickenham, Middlesex, U.K.
RESULTS

Purification of acid phosphatase
The tartrate-resistant enzyme was purified by sequential chromatography on SP-Sephadex, CM-Sephadex, hydroxylapatite, Sephadex G-150 and concanavalin A-Sepharose by 2000-fold over the tumour homogenate supernatant, with a yield of 10 % and a specific activity of 387 units* mg-'. The purification summary is shown in Table 1 . The first chromatographic stage on SP-Sephadex removes most of the contaminating proteins including a high-Mr acid phosphatase which is partially tartratesensitive. This partly accounts for the low recovery of enzyme activity. The affinity of the enzyme for concanavalin A suggests it is a glycoprotein, although we have no further information on the carbohydrate content. SDS/polyacrylamide-gel electrophoresis of the purified enzyme indicated an Mr of 30000 under non-reducing conditions (Fig. 1 ). This value was in agreement with that obtained by gel filtration. Under reducing conditions a major band was observed with an Mr of 15000, and a diffuse band with an Mr of about 17500 (Fig. 2 ). Reverse-phase h.p.l.c. of the purified enzyme revealed a major protein peak ( Fig. 3 ) which coincided with enzyme activity (results not shown). After purification by h.p.l.c. and subsequent reduction and alkylation with 4-vinylpyridine [22] , two protein peaks were observed ( Fig. 3 ). SDS/polyacrylamide-gel electrophoresis demonstrated that peak B corresponded to the Mr 17500 subunit and peak A to the Mr-15000 subunit (Fig. 4 ). Peak B was usually a doublet. Alkylation resulted in complete loss of enzyme activity. N-Terminal amino acid analysis of subunits A and B revealed a high degree of identity with the N-terminal sequence of the subunits of bovine spleen tartrate-resistant acid phosphatase and with the N-terminus and an internal sequence of pig uteroferrin (Fig. 5) . A search of the National Biological Research Foundation protein sequence data bank also revealed that the N-terminus of the B subunit was 41 % identical to a sequence near the N-terminus of the proteolipid subunit of maize mitochondrial FO-ATPase [23] (Fig. 6 ). N-Terminal amino acid sequence analysis of the leading and trailing edge of the B subunit yielded identical sequences.
The metal content of the enzyme was determined by atomic absorption spectroscopy. The purified enzyme contained 4.8 mol of iron, 0.3 mol of manganese and 1.7 mol of magnesium per mol of enzyme. A similar analysis of an acid collagenase also purified from osteoclastomas [24] contained negligible quantities of these three metals. Substrate specificity
The hydrolysis of natural and synthetic substrates was investigated ( Table 2) . Preferred substrates were the artificial compounds p-nitrophenyl phosphate, 4methylumbelliferyl phosphate and the nucleoside tri-and diphosphates, whereas the nucleoside monophosphates, pyrophosphate, the phosphoprotein phosvitin and sugar phosphates were poor substrates, activity being undetected in the assay system (Table 2 ). Values were calculated using Lineweaver-Burk plots. When the results are calculated as kcat./Km, the most efficiently hydrolysed substrates were ATP and GTP. The optimum pH was 5.5-5.7 in sodium acetate buffer for all substrates.
The enzyme was stable in the pH range 4-7 (results not shown).
Inhibition studies
A product inhibition analysis of the purified enzyme was carried out. A Lineweaver-Burk plot at various concentrations of phosphate indicated that it was a competitive inhibitor of the enzyme with a Ki of 0.75 mm analogue of phosphate, was a much less potent inhibitor of the enzyme than molybdate. In addition, the inhibition was non-competitive with a K, of 3.1 mm (Table 3 ). The slopes and intercepts of the inhibitor plots were determined by least-squares regression analysis. The majority of tartrate-resistant acid phosphatases are activated by reducing agents (e.g. 2-mercaptoethanol, ascorbic acid, Fe2") and inhibited by divalent cations with low oxidation potential, suggesting that sulphydryl groups are required for activity. However, the osteoclastoma enzyme was inhibited by reducing agents although it was also inhibited in a non-competitive manner by a variety of divalent metal ions (Table 3) .
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Copper was the most potent inhibitor, with a Ki of 6.8 /uM, whereas Fe2" was the least effective inhibitor with a K, of 800 /,tM. Zn2+ has been shown to be an uncompetitive inhibitor of the enzyme from bovine cortical bone matrix, whereas the inhibition by Fe2" is partially noncompetitive [25] . Unlike other tartrate-resistant acid phosphatases, the osteoclastoma enzyme is inhibited by EDTA, suggesting a requirement for a divalent cation(s). The rates of hydrolysis of methylumbelliferyl phosphate, ATP and GTP by the osteoclastoma enzyme are increased, to a small extent, by both Mg2" and Mn2". A summary of inhibitors of the osteoclastoma enzyme is shown in Table 3 .
DISCUSSION
Tartrate-resistant acid phosphatases have been purified from a number of sources including Gaucher spleen [6] , bovine spleen [7] , spleens of patients with hairy cell leukaemia [13] , human, bovine and rat bone [25, [28] [29] [30] , lung [31] , and pig uterus [32] . These enzymes share a number of properties, including M, values of 30000-40000, pH optima of 5-6, and extreme sensitivity to inhibition by molybdate. Although the enzyme has previously been purified from bone [25, 28, 29] , these studies utilized non-human tissue, and moreover the cellular source of these enzymes is not entirely clear. We have purified, to apparent homogeneity, a tartrateresistant acid phosphatase from human osteoclastomas in which the osteoclast is a major cell type. The specific activity of the purified enzyme from bone is generally about 10-fold lower than that of the spleen enzyme [13, 26, 27] . The final specific activity of the osteoclastoma enzyme was 387 units mg-'.
The subunit structure of the osteoclastoma enzyme is similar to that reported for the tartrate-resistant acid phosphatase purified from bovine spleen [27] , and the N-termini of both subunits show extensive sequence similarities with the N-termini of the spleen enzyme subunits [33] . However, the B subunit is considerably smaller than the corresponding subunit of the spleen enzyme, having an Mr of 17500 compared with 24000 for the spleen enzyme subunit. An enzyme purified from rat bones has subunits of similar size to those of the osteoclastoma enzyme [34] . In addition, both osteoclastoma enzyme subunits lack the two N-terminal amino acids found in the spleen enzyme subunits. The Nterminal sequences of both osteoclastoma and spleen enzymes are similar to the sequence of tartrate-resistant acid phosphatase (also known as uteroferrin) purified from pig uterus. However, this latter enzyme is synthesized as a single polypeptide. The N-termini of these enzymes also show about 400°0 identity with that of Vol. 261 ( Fig. 7) . Methylumbelliferone, at concentrations up to 4 mM, had no effect on the activity of the enzyme (results not shown). Transition-state analogues of phosphate such as molybdate were potent inhibitors of the osteoclastoma enzyme. The inhibition by molybdate was competitive, with a Ki of 0.18 /SM (Fig. 8 ). As discussed by Lau et al. [25] , these results are consistent with a pseudo Uni/Bi hydrolytic two-step transfer reaction mechanism involving the formation of a covalent phosphoryl-enzyme intermediate. However, fluoride, which has also been suggested to act as a transition-state Fo-ATPase which acts as a proton pump. Osteoclasts contain an active proton pump which acidifies the space between the osteoclast and the bone surface, resulting in the breakdown of bone mineral [35] . Clearly, further investigations are required to determine if tartrateresistant acid phosphatases contribute to proton transport. Tartrate-resistant acid phosphatases do not appear to share any sequence identity with lysosomal acid phosphatase [36] . We also investigated a number of characteristics of the osteoclastoma enzyme in order to determine if this enzyme had substantially different properties from other tartrate-resistant acid phosphatases. Acid phosphatases from both spleen and bone contain iron, and this may be essential for activity [27, 29] . The osteoclastoma enzyme Table 3 . Effect of compounds on the activity of acid phosphatase Several compounds were tested for their ability to inhibit acid phosphatase. These were included in the reaction mixture and the effects determined fluorimetrically. n.d., not determined. Vol. 261 607 I contains 4.8 mol of iron per mol of protein. Although the osteoclastoma enzyme was inhibited by EDTA, the iron chelator phenanthroline had no effect on enzyme activity, suggesting either that the iron is inaccessible to chelators, or that it is not required for the activity of tartrateresistant acid phosphatase. Indeed, the enzyme is inhibited by Fe2" at all concentrations tested. Both Mn2+ and Fe2' have been reported to be activators of the enzyme purified from bovine cortical bone matrix [25] . An acid phosphatase containing Mn2' but not Fe2+ has been reported to be present in sweet potatoes [37] but this has been disputed [38] . The enzyme purified from whole rat bone has been reported to be activated by Fe2+ and to be resistant to EDTA [28, 29] . These results suggest that there are differences in the metal requirements of acid phosphatases purified from whole bones and from osteoclastomas.
Concentration
The role of acid phosphatases in vivo is unclear. The osteoclastoma enzyme might play a role in the dissolution of bone mineral. Contradictory reports exist concerning the pyrophosphatase activity of the enzyme purified from whole bone [28, 29] , whereas the spleen enzyme hydrolysed pyrophosphate relatively efficiently when isolated from the spleens of patients with hairy-cell leukaemia [13] but not when isolated from Gaucher spleen [26] . Possibly one enzyme is derived from B cells and the other from macrophages. We were unable to demonstrate any activity towards pyrophosphate by the osteoclastoma enzyme. Although bone contains phosphoproteins, the osteoclastoma enzyme was similar to those isolated from rat bone and Gaucher spleen in that it failed to dephosphorylate the phosphoprotein phosvitin [26, 29] . The tartrate-resistant acid phosphatase purified from bovine cortical bone matrix has been shown to dephosphorylate histones [25] . The significance of the hydrolysis of nucleoside tri-and diphosphates is unclear, unless the enzyme is related to a proton pump.
They are usually hydrolysed at 25-l10 %0 of the rate of synthetic substrates [13, 26, 28, 29] . The osteoclastoma enzyme hydrolysed these compounds at 30-60 %0 of the rate of hydrolysis ofp-nitrophenyl phosphate, unlike the enzyme from bovine cortical bone matrix where the rate of hydrolysis is only 7-15 %0 [25] .
Studies on the structure, substrate specificity, the effects of inhibitors and activators, and metal ion requirements have demonstrated that there are some similarities and differences between the osteoclastoma tartrate-resistant acid phosphatase and similar enzymes purified from whole bone and other sources. It is known that several cell types, including macrophages, red cells and osteoblastic cells, all of which are present in whole bone, also contain small amounts of tartrate-resistant acid phosphatase [9, 31, 39] , and since whole bone contains only small numbers of osteoclasts compared with these cell types, the source of tartrate-resistant acid phosphatase in some of these studies remains unclear.
The source of our enzyme was chosen specifically for its high content of osteoclasts. Since the osteoclast enzyme is secreted during bone resorption, more specific identification of the enzyme may enable improved assays to be developed for osteoclastic function in vivo and in vitro. This investigation was supported, in part, by grants from The Cancer Research Campaign and The Medical Research Council.
